Creo Medical Group PLC (AIM:CREO), a specialist in surgical endoscopy, has achieved a new milestone with the successful deployment of its Speedboat UltraSlim device in the Asia Pacific region.
It was used at the Prince of Wales Hospital in Hong Kong by doctors Hon Chi Yip and Simon Chu who performed procedures targeting precancerous lesions in the colon and stomach.
Since its introduction, Speedboat UltraSlim has been successfully implemented in multiple clinical settings across various regions, including the UK, USA, Latin America, and now the Asia Pacific.
Creo chief executive Craig Gulliford told investors: "We're very pleased that Speedboat UltraSlim has now reached the Asia Pacific region, representing tremendous progress with the phased initial market release in a short period of time.
"The team have done a terrific job with the regional regulatory steps necessary to enable this limited market release programme and we are excited to extend the roll-out to reach all of our customers in the coming months.
"APAC represents the fourth continent where the device has now been used in clinic and along with Dr Hon Chi Yip and Dr Simon Chu, we have had fantastic feedback from all customers who have so far had access to the new technology."